It attributes that gap to fundamental differences in mechanism and potency, not dosage
At each visit, clinicians should assess: Weight loss progress Saxenda should be discontinued if patients have not lost at least 5% of initial body weight after 12 weeks on the 3.0 mg daily dose Tolerability and adverse effects particularly gastrointestinal symptoms, which usually improve over time Blood glucose monitoring especially in diabetic patients, as weight loss and liraglutide's effects may necessitate adjustment of other glucose-lowering medications (particularly sulfonylureas or insulin) to prevent hypoglycaemia Blood pressure and heart rate liraglutide can cause modest increases in heart rate Autoimmune disease activity any changes in symptoms or disease control should be discussed with the relevant specialist Patients should be advised to contact their GP immediately if they experience severe abdominal pain (possible pancreatitis), signs of thyroid masses, symptoms of gallbladder disease (right upper quadrant pain, jaundice), or worsening of their autoimmune condition
Expert opinion on pharmacotherapy
You want a broad branded GLP-1 selection from a single telehealth platform
Liraglutide and semaglutide: pooled post-hoc analysis to evaluate risk of dementia in patients with type 2 diabetes
Los mdicos advierten sobre los graves problemas de salud a largo plazo causados por la prdida regular de masa muscular en pacientes que han adoptado un rgimen de prdida y recuperacin de peso en forma de yoyo
